These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12215269)

  • 1. High in vivo production of a model monoclonal antibody on adenoviral gene transfer.
    Noël D; Pelegrin M; Kramer S; Jacquet C; Skander N; Piechaczyk M
    Hum Gene Ther; 2002 Aug; 13(12):1483-93. PubMed ID: 12215269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin as a potential organ for ectopic monoclonal antibody production.
    Noël D; Dazard JE; Pelegrin M; Jacquet C; Piechaczyk M
    J Invest Dermatol; 2002 Feb; 118(2):288-94. PubMed ID: 11841546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatable systemic production of monoclonal antibodies by in vivo muscle electroporation.
    Perez N; Bigey P; Scherman D; Danos O; Piechaczyk M; Pelegrin M
    Genet Vaccines Ther; 2004 Mar; 2(1):2. PubMed ID: 15038826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sustained muscle expression of dystrophin from a high-capacity adenoviral vector with systemic gene transfer of T cell costimulatory blockade.
    Jiang Z; Schiedner G; van Rooijen N; Liu CC; Kochanek S; Clemens PR
    Mol Ther; 2004 Oct; 10(4):688-96. PubMed ID: 15451453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An antibody delivery system for regulated expression of therapeutic levels of monoclonal antibodies in vivo.
    Fang J; Yi S; Simmons A; Tu GH; Nguyen M; Harding TC; VanRoey M; Jooss K
    Mol Ther; 2007 Jun; 15(6):1153-9. PubMed ID: 17375065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained systemic delivery of monoclonal antibodies by genetically modified skin fibroblasts.
    Noël D; Pelegrin M; Brockly F; Lund AH; Piechaczyk M
    J Invest Dermatol; 2000 Oct; 115(4):740-5. PubMed ID: 10998153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ex vivo gene transfer to mature skeletal muscle by using adenovirus helper cells.
    Kimura S; Ikezawa M; Cao B; Kanda Y; Pruchnic R; Cummins J; Huard J; Miike T; Suzuki S
    J Gene Med; 2004 Feb; 6(2):155-65. PubMed ID: 14978769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local high-capacity adenovirus-mediated mCTLA4Ig and mCD40Ig expression prolongs recombinant gene expression in skeletal muscle.
    Jiang ZL; Reay D; Kreppel F; Gambotto A; Feingold E; Kochanek S; McCarthy SA; Clemens PR
    Mol Ther; 2001 Jun; 3(6):892-900. PubMed ID: 11407903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term transgene expression in cardiac and skeletal muscle following fetal administration of adenoviral or adeno-associated viral vectors in mice.
    Bouchard S; MacKenzie TC; Radu AP; Hayashi S; Peranteau WH; Chirmule N; Flake AW
    J Gene Med; 2003 Nov; 5(11):941-50. PubMed ID: 14601131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of high-capacity and first-generation adenoviral vector gene delivery to murine muscle in utero.
    Bilbao R; Reay DP; Wu E; Zheng H; Biermann V; Kochanek S; Clemens PR
    Gene Ther; 2005 Jan; 12(1):39-47. PubMed ID: 15483668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted cancer immunotherapy with oncolytic adenovirus coding for a fully human monoclonal antibody specific for CTLA-4.
    Dias JD; Hemminki O; Diaconu I; Hirvinen M; Bonetti A; Guse K; Escutenaire S; Kanerva A; Pesonen S; Löskog A; Cerullo V; Hemminki A
    Gene Ther; 2012 Oct; 19(10):988-98. PubMed ID: 22071969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response after adenoviral gene transfer in syngeneic heart transplants: effects of anti-CD4 monoclonal antibody therapy.
    Schröder G; Risch K; Nizze H; Kolls J; Reinke P; Brock J; Lehmann M; Volk HD; Ritter T
    Transplantation; 2000 Jul; 70(1):191-8. PubMed ID: 10919599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Passive immune-prophylaxis against influenza virus infection by the expression of neutralizing anti-hemagglutinin monoclonal antibodies from plasmids.
    Yamazaki T; Nagashima M; Ninomiya D; Arai Y; Teshima Y; Fujimoto A; Ainai A; Hasegawa H; Chiba J
    Jpn J Infect Dis; 2011; 64(1):40-9. PubMed ID: 21266754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ICAM-2 monoclonal antibody synergizes with intratumor gene transfer of interleukin-12 inhibiting activation-induced T-cell death.
    Melero I; Gabari I; Tirapu I; Arina A; Mazzolini G; Baixeras E; Feijoo E; Alfaro C; Qian C; Prieto J
    Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3546-54. PubMed ID: 14506140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged islet allograft survival by adenovirus-mediated transfer of sICAM-1/Ig immunoadhesin gene.
    Barrou B; Bertry-Coussot L; Morin S; Sainz J; Lucas B; Bitker MO; Debré P; Lemarchand P
    Hum Gene Ther; 2002 Aug; 13(12):1441-50. PubMed ID: 12215265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of costimulation allows for repeated systemic administration of adenoviral vector in rhesus monkeys.
    Haegel-Kronenberger H; Haanstra K; Ziller-Remy C; Ortiz Buijsse AP; Vermeiren J; Stoeckel F; Van Gool SW; Ceuppens JL; Mehtali M; De Boer M; Jonker M; Boon L
    Gene Ther; 2004 Feb; 11(3):241-52. PubMed ID: 14737083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional 'pro-drug' gene therapy: intravenous administration of an adenoviral vector expressing the E. coli cytosine deaminase gene and systemic administration of 5-fluorocytosine suppresses growth of hepatic metastasis of colon carcinoma.
    Topf N; Worgall S; Hackett NR; Crystal RG
    Gene Ther; 1998 Apr; 5(4):507-13. PubMed ID: 9614575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibody-based genetic immunotherapy.
    Pelegrin M; Gros L; Dreja H; Piechaczyk M
    Curr Gene Ther; 2004 Sep; 4(3):347-56. PubMed ID: 15384948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stabilization of transgene expression by incorporation of E3 region genes into an adenoviral factor IX vector and by transient anti-CD4 treatment of the host.
    Poller W; Schneider-Rasp S; Liebert U; Merklein F; Thalheimer P; Haack A; Schwaab R; Schmitt C; Brackmann HH
    Gene Ther; 1996 Jun; 3(6):521-30. PubMed ID: 8789802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
    Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
    Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.